Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic
Na minha lista:
Santomauro, D., et al., Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. The Lancet, n. 398, 2021, p. 1700-1712.
Ref.
577769
Localização:
SIIS Archivo (R.484)
Palabras clave:
Salud mental, Depresión, Ansiedad, COVID, Efectos, Riesgo, Mortalidad, Salud, Medición, Datos estadísticos, Estudio comparativo, Panorama internacional
Salud mental, Depresión, Ansiedad, COVID, Efectos, Riesgo, Mortalidad, Salud, Medición, Datos estadísticos, Estudio comparativo, Panorama internacional
Registos relacionados: Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic
- Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
- Impact of confinement measures due to the COVID-19 pandemic on people living with dementia and their caregivers in Spain
- Coping behaviors associated with decreased anxiety and depressive symptoms during the COVID-19 pandemic and lockdown
- Increased alcohol use to cope with COVID-19-related anxiety one year into the coronavirus pandemic
- Anxiety and depressive symptoms in children and adolescents during COVID-19 pandemic: A transcultural approach
- Prevalence of depression, anxiety, burden, burnout, and stress in informal caregivers: An umbrella review of meta-analyses